S100A4 and pemphigus foliaceus: Both the WB (Figure 2A) and IHC (Figure 2B) data showed that the protein level of S100A4 was significantly increased after BLM treatment, but MET administration reversed this change, indicating that MET mediated anti-fibrosis in PF by targeting S100A4.